Public health and safety; Oklahoma Public Health and Safety Reform Act of 2025; effective date.
Kansas HB 2296 would eliminate patient cost-sharing for diagnostic and supplemental breast imaging used to evaluate or screen for breast cancer.
Kansas HB 2296 would eliminate patient cost-sharing for diagnostic and supplemental breast imaging used to evaluate or screen for breast cancer.
Summary: This bill would require many Kansas health plans to eliminate patient cost‑sharing (deductibles, coinsurance, copayments, or similar out‑of‑pocket charges) for diagnostic and supplemental breast examinations used to evaluate or screen for breast cancer, subject to a limited exception for certain HSA‑qualified high‑deductible plans under federal law.
Ensure insured patients do not face out‑of‑pocket cost barriers when receiving medically necessary diagnostic or supplemental breast examinations for breast cancer, thereby promoting timely follow‑up after abnormal screening or enhanced screening for higher‑risk individuals.
Notes:
- The bill text uses the phrase “delivered, issued for delivery, amended or renewed on or before January 1, 2026.” That timing language is part of the introduced draft; readers may wish to confirm whether the intended application date is correct or whether later revisions amend that date/phrase.
- Multiple unrelated legislative documents exist for bills numbered HB 2296 in various states; this summary addresses the Kansas health‑insurance version reflected in the fiscal note and introduced text.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.